Donald Bellgrau
Affiliations: | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Immunology, Cell Biology, GeneticsGoogle:
"Donald Bellgrau"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Modiano JF, Lindborg BA, McElmurry RT, et al. (2015) Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment. Cancer Immunology, Immunotherapy : Cii. 64: 1449-60 |
King TH, Kemmler CB, Guo Z, et al. (2014) A whole recombinant yeast-based therapeutic vaccine elicits HBV X, S and Core specific T cells in mice and activates human T cells recognizing epitopes linked to viral clearance. Plos One. 9: e101904 |
May SL, Zhou Q, Lewellen M, et al. (2014) Nfatc2 and Tob1 have non-overlapping function in T cell negative regulation and tumorigenesis. Plos One. 9: e100629 |
Tamburini BA, Kedl RM, Bellgrau D. (2012) IL-6-inducing whole yeast-based immunotherapy directly controls IL-12-dependent CD8 T-cell responses. Journal of Immunotherapy (Hagerstown, Md. : 1997). 35: 14-22 |
Jubala CM, Lamerato-Kozicki AR, Borakove M, et al. (2009) MHC-dependent desensitization of intrinsic anti-self reactivity. Cancer Immunology, Immunotherapy : Cii. 58: 171-85 |
Modiano JF, Johnson LD, Bellgrau D. (2008) Negative regulators in homeostasis of naïve peripheral T cells. Immunologic Research. 41: 137-53 |
Kupfer R, Lang J, Williams-Skipp C, et al. (2007) Loss of a gimap/ian gene leads to activation of NF-kappaB through a MAPK-dependent pathway. Molecular Immunology. 44: 479-87 |
Jubala CM, Wojcieszyn JW, Valli VE, et al. (2005) CD20 expression in normal canine B cells and in canine non-Hodgkin lymphoma. Veterinary Pathology. 42: 468-76 |
Lang JA, Kominski D, Bellgrau D, et al. (2004) Partial activation precedes apoptotic death in T cells harboring an IAN gene mutation. European Journal of Immunology. 34: 2396-406 |
Frazer-Abel AA, Baksh S, Fosmire SP, et al. (2004) Nicotine activates nuclear factor of activated T cells c2 (NFATc2) and prevents cell cycle entry in T cells. The Journal of Pharmacology and Experimental Therapeutics. 311: 758-69 |